NCT00446446 2022-10-05PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)AmgenPhase 2 Completed52 enrolled 17 charts
NCT00513383 2017-03-01Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and NeckMassachusetts General HospitalPhase 1 Completed34 enrolled